ADURO BIOTECH, INC. (ADRO) has 142 open-market insider trades by 17 insiders since 2015. The most active filer is Stephen T. Isaacs, CEO & President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Stephen T. Isaacs | CEOPres | — | 37 | $11.0M | 2020-09-15 |
| Thomas W. Dubensky | CSO | — | 25 | $9.3M | 2017-08-11 |
| Morningside Venture (VI) Investments Ltd | 10% Owner | — | 1 | $7.5M | 2016-02-18 |
| Gregory W. Schafer | COO | — | 12 | $4.1M | 2018-01-25 |
| Dirk G. Brockstedt | VP | — | 15 | $3.1M | 2017-12-29 |
| John E. And Lois A. Rogers | 10% | — | 2 | $2.8M | 2015-04-20 |
| Jennifer Lew | CFO | — | 18 | $1.4M | 2019-05-01 |
| Thomas W. Dubensky | CSO | — | 1 | $569K | 2017-08-11 |
| Andrea van Elsas | CSO | — | 10 | $550K | 2020-02-25 |
| Gregory W. Schafer | COO | — | 2 | $525K | 2018-01-25 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Celeste Ferber | Secretary & SVP | Sell | $6K | 2020-09-15 |
| Stephen T. Isaacs | CEO & President | Sell | $155K | 2020-09-15 |
| Blaine Templeman | CLO | Sell | $30K | 2020-09-15 |
| Blaine Templeman | CLO | Sell | $20K | 2020-08-07 |
| Nuyten Dimitry SA | Chief Medical Officer | Sell | $9K | 2020-08-07 |
| Andrea van Elsas | Chief Scientific Officer | Sell | $24K |
Companies that share insiders with ADRO, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2020-02-25 |
| Andrea van Elsas | CSO | Sell | $174K | 2020-01-03 |
| Blaine Templeman | CLO | Sell | $1K | 2019-12-12 |
| Stephen T. Isaacs | President | Sell | $7K | 2019-12-12 |
| Celeste Ferber | Secretary & SVP | Sell | $473 | 2019-12-12 |
| Andrea van Elsas | Chief Scientific Officer | Sell | $3K | 2019-12-12 |
| Andrea van Elsas | Chief Scientific Officer | Sell | $24K | 2019-09-13 |
| Stephen T. Isaacs | President | Sell | $41K | 2019-09-13 |
| Blaine Templeman | CLO | Sell | $17K | 2019-09-13 |
| Celeste Ferber | Secretary & SVP | Sell | $3K | 2019-09-13 |